No particular news except Seeking Alpha
has been following it publicly on positive moves.
Premarket Gainers as of 9:10 am
SA News•Today, 9:20 AM•1 Comment
After Hours Gainers / Losers
SA News•Yesterday, 5:35 PM•1 Comment
Midday Gainers / Losers
SA News•Yesterday, 12:43 PM
Healthcare- Top 5 Gainers / Losers as of 12:15 PM
SA News•Yesterday, 12:15 PM
Cerulean up 44% in early trading
SA News•Yesterday, 10:46 AM•12 Comments
Premarket Gainers / Losers as of 9:10 am
SA News•Yesterday, 9:15 AM
Premarket Gainers / Losers as of 9:10 am
SA News•Tue, Mar. 14
Midday Gainers / Losers
SA News•Mon, Mar. 13•13 Comments
Healthcare - Top 5 Gainers / Losers as of 12:10 PM
SA News•Mon, Mar. 13•2 Comments
Premarket Gainers / Losers as of 9:10 am
SA News•Mon, Mar. 13•3 Comments
Healthcare - Top 5 Gainers / Losers as of 11:00 am
SA News•Thu, Feb. 9•2 Comments
Healthcare - Top 5 Gainers / Losers as of 11:00 am
SA News•Tue, Feb. 7•8 Comments
Premarket Gainers / Losers as of 9:10 am
SA News•Mon, Feb. 6•4 Comments
Cerulean Pharma receives deficiency notice from Nasdaq
SA News•Nov. 18, 2016•6 Comments
Cerulean Pharma Inc. SEC Filing - Current report (8-K) November 18, 2016
SEC Filings•Nov. 18, 2016
Other News
3 Reasons Why Cerulean Pharma (CERU) is a Great Momentum Stock
at Zacks.com (Jan 9, 2017)
Cerulean Announces Promotion Of Scott Eliasof, PhD To Senior Vice President And Chief Scientific Officer
at TheStreet (Oct 26, 2016)
First Week of June 2017 Options Trading For Cerulean Pharma (CERU)
at TheStreet (Oct 25, 2016)
Mid-Day Market Update: Crude Oil Up 2.75%; Cerulean Pharma Shares Surge On News Of Novartis Collaboration
at Benzinga (Oct 19, 2016)
Cerulean Stock Shoots Higher On News Of Novartis Collaboration
at Benzinga (Oct 19, 2016)
Cerulean Announces Technology Platform Collaboration
at TheStreet (Oct 19, 2016)
Cerulean Announces Data Presentations At The 2016 European Society For Medical Oncology Annual Meeting
at TheStreet (Oct 6, 2016)
Barclays Remains Positive On Cerulean Pharma Despite Failed Renal Cancer Trial
at Benzinga (Aug 30, 2016)
Cerulean Announces Reduction In Force
at TheStreet (Aug 18, 2016)
Cerulean Pharma (CERU) Stock Tumbles on Lead Kidney Cancer Drug Failure
at TheStreet (Aug 18, 2016)
Cerulean Pharma Inc., a clinical-stage company, develops nanotechnology-based therapeutics in the areas of oncology and other diseases in the United States. The companys lead product candidate is CRLX101, a tumor targeted nanoparticle-drug conjugate (NDC), which is in Phase 2 clinical development in patients with renal cell carcinoma; and in Phase 2 and Phase 1b clinical development in patients with ovarian cancer. It is also developing CRLX301, a platform-generated NDC clinical candidate, which is in Phase 1/2a clinical trials. The company has a strategic collaboration with Novartis to develop nanoparticle-drug conjugates for various cancer tumor targets. The company was formerly known as Tempo Pharmaceuticals, Inc. and changed its name to Cerulean Pharma Inc. in October 2008. Cerulean Pharma Inc. was incorporated in 2005 and is based in Waltham, Massachusetts.
Expanding Expertise in Westchester Today's eye care landscape just got a bit tighter up in Yonkers. SightMD's hauled in a new ace—Dr. Brittany M. Perzia. This isn't your run-of-the-mill hire. The good doctor packs a solid punch in Cornea & External Disease, aiming her skills at the folks around Westchester. It's not just about the numbers with her, though. Her resume's...
Who would've thought your morning coffee ritual could be in cahoots with a silent tooth villain? Well, Dr. Kari Sakurai at Pacific View Smile Center slices through the noise with some fascinating insights on early tooth decay, spun out in an article by HelloNation. You see, Dr. Sakurai, like a dental James Bond, is fighting the good fight against cavities before they even...
You know, the market's all abuzz with AI this, AI that. But today, we're getting a glimpse at something that isn't just hyped-up vaporware; it's actually useful. Clarivate Plc (NYSE:CLVT), which has carved a niche in transformative intelligence, is teaming up with Microsoft to slide their CompuMark trademark data into Microsoft Copilot via something they call IPOne. It's...
A New Takeoff for Airline B2B Payments Dusting off the cobwebs of traditional payment processes, YeePay has been busy at the 2026 IATA WFS & WPS, held on the glitzy floor of the Galaxy International Convention Center in Macau from October 28 to 29. They're not just chatting about travel; they're rolling out a novel way to tackle the headaches in airline B2B order...
AppLovin’s Alleged Missteps: Investors Speak Up Earlier this year, folks holding AppLovin shares were sold a story of grand ambitions. The company's focus was on the promise of AI—dreams of skyrocketing revenue through innovative tools and self-service platforms. But as those promises struggled to take shape, investors pulled back the curtain, and the legal eagles...
Shaping the Skyline with Life Time Living Right in the heart of Midtown Raleigh, they're drawing lines in the sand for what the future of upscale living will look like. On October 29, Dewitt Carolinas and Life Time (NYSE: LTH) officially broke ground on Life Time Living at The Exchange Raleigh. Sure, groundbreaking ceremonies happen all the time, but this one sends a...
Riding the Tactical Communication Wave Alright, here’s something to chew on over your morning coffee. The tactical communication market is projected to balloon from USD 13.14 billion in 2026 to a whopping USD 19.39 billion by 2031. That’s an 8.1% CAGR if you’re keeping track—no small peanuts. So what's driving this surge? It’s all about security, modernization,...
Just when you think the circus of energy utilities couldn't get any more outlandish, PG&E grabs the spotlight once more. Picture this: they've got the megaphone out, threatening to put the brakes on $2 billion in crucial infrastructure investments. Twenty-five thousand customers left hanging, just waiting for their lights to come on. As if that's not enough, PG&E is also...
Building a Home in Tucson: Timing is Everything Ask anyone who's ever dreamed of their own custom-built home—patience isn't just a virtue, it's a necessity. In Tucson, Arizona, where the landscape is as captivating as it is challenging, Home Remodeling Expert Robin Hartman breaks down exactly what homeowners should expect when embarking on a home build. Hartman, through...
Fielding Excellence on Display: The 2026 Rawlings Gold Glove Awards The Rawlings Gold Glove Awards have once again shone the spotlight on baseball's defensive maestros. Announced by Rawlings Sporting Goods Company, Inc., on November 1, 2026, this year's winners include 11 seasoned veterans and nine greenhorns who claimed their first-ever Gold Gloves. Unveiled during a...
Bank of England Keeps Interest Rate at 5.0% The Bank of England has announced that it will keep its benchmark interest rate steady at 5.0%. This decision reflects the central bank's cautious stance, as it seeks to make gradual adjustments to its policy following a recent rate reduction. Understanding the Economic Factors Involved The decisions made by the Bank of England...
Out there in the bustling world of marketing, a new heavyweight tool just rolled off the assembly line, and it's packing some serious AI clout. Infosys team has teamed up with the ANA and LIONS to sling their latest creation, the CMO AI Hub. This isn’t some run-of-the-mill software—they've thrust a spotlight directly on the marketers in the driver's seat of the...
MillerKnoll's Stock Reaction to Recent Financial Results MillerKnoll, Inc. (NASDAQ: MLKN) has experienced a significant dip in its stock price after revealing its first-quarter financial results. This decline emphasizes how quickly investors react to a company's performance, highlighting the critical role of financial health in maintaining investor confidence. Key...
Celebrate the Life of Betty White with New Forever Stamps In a delightful tribute, the U.S. Postal Service has introduced new Forever stamps showcasing the legendary entertainer Betty White. These charming creations are designed to brighten up any mailpiece, adding a cheerful note to the everyday correspondence we send. Whether it’s a letter to a friend or a card for a...
Tyra Biosciences to Host Virtual Fireside Chat Tyra Biosciences, Inc. (Nasdaq: TYRA), a biotech firm immersed in developing advanced precision medicines, is set to participate in an engaging fireside chat that focuses on significant health issues such as achondroplasia and growth disorders. This impactful discussion is part of the UBS Biotech Management Live Call Series...